You can buy or sell LMAT and other stocks, options, ETFs, and crypto commission-free!
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Read More Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
52 Week High
52 Week Low
Simply Wall StMar 17
At US$31.27, Is It Time To Put LeMaitre Vascular, Inc. (NASDAQ:LMAT) On Your Watch List?
LeMaitre Vascular, Inc. (NASDAQ:LMAT), which is in the medical equipment business, and is based in United States, led the NASDAQGM gainers with a relatively large price hike in the past couple of weeks. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Today I will analyse the most recent data on LeMaitre Vascular’s outlook and valuation to see if the opportunity still...
Stock Price, News, & Analysis for LeMaitre Vascular
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It also provides carotid s...
Simply Wall StFeb 28
Is LeMaitre Vascular, Inc.’s (NASDAQ:LMAT) CEO Salary Justified?
In 1992 George LeMaitre was appointed CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we’ll consider growth that the business demonstrates. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO. View our latest analysis fo...
Expected Apr 24, After Hours